Comparative study on Kawasaki disease between Japan and North America
日本与北美川崎病的比较研究
基本信息
- 批准号:09044347
- 负责人:
- 金额:$ 6.14万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for international Scientific Research
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The objective of this project was to investigate of comparative evaluation between Japan and United States in terms of epidemiology, pathophysiology and treatment of Kawasaki disease. In the area of epidemiology, Yanagawa demonstrated the result of Japanese nationwide survey, especially the transition of patient's population, cardiac sequelae, mortality, recurrent rate and incidence of sibling case. Pathophysiological role of IgA plasma cells in vascular tissue during the acute stage was evaluated by Shulman and colleagues. Newberger and colleagues suggested that coronary arterial dimensions evaluated by echocardiography might be misclassified as normal in Kawasaki disease. Although the criteria of Japanese Ministry of Health is only published criteria the specifically define coronary artery abnormality in this disease, coronary artery dimensions in normal children have been shown to increase linearly with indices of body size, such as body surface area or body length. They introduced … More the data of body surfacarea corrected coronary dimensions. In the therapeutic area, Takahashi and colleagues introduced of low-dose wairfarin plus aspirin therapy in patients complicated with giant coronary aneurysm, which cause of myocardial infarction. Controversy has been persisted how to treat the patients who resisted initial gamma globulin treatment. Kato and colleagues demonstrated the clinical trail of steroid pulse therapy in such patients. Their current results shown the incidence of coronary artery lesion was not different between steroid pulse and gamma globulin therapy, however medical cost of steroid pulse therapy tend to be lower. Further investigation in this area should be required. Other topics of treatment were relatedof coronary artery involvements and its long-term outcome. Result of Japanese nationwide survey of catheter intervention was reported their importance as a new therapeutic strategies. Kato and colleagues reported that the presence of endothelial dysfunction at the site of regressed coronary aneurysm using direct infusion of aceylcholine. Less
本研究的目的是探讨日本与美国在川崎的流行病学、病理生理学及治疗方面的比较评估。在流行病学方面,柳川展示了日本全国调查的结果,特别是患者人群的变迁、心脏后遗症、死亡率、复发率和同胞病例的发生率。Shulman及其同事评价了急性期血管组织中伊加浆细胞的病理生理作用。Newberger及其同事认为,在川崎病患者中,超声心动图评估的冠状动脉直径可能被错误分类为正常。虽然日本卫生部的标准只是专门定义这种疾病中冠状动脉异常的标准,但正常儿童的冠状动脉尺寸已被证明与身体尺寸指数(如体表面积或体长)呈线性增加。他们介绍 ...更多信息 体表面积数据校正冠状动脉尺寸。在治疗领域,Takahashi及其同事介绍了小剂量阿司匹林加阿司匹林治疗合并巨大冠状动脉瘤的患者,这些患者导致心肌梗死。如何治疗最初抵抗丙种球蛋白治疗的患者一直存在争议。Kato和他的同事证明了类固醇脉冲疗法在这些患者中的临床试验。他们目前的研究结果显示,类固醇脉冲和丙种球蛋白治疗的冠状动脉病变发生率没有差异,但类固醇脉冲治疗的医疗费用往往较低。应要求在这方面作进一步调查。其他治疗主题与冠状动脉受累及其长期结局有关。日本全国导管介入调查的结果报告了导管介入作为一种新的治疗策略的重要性。Kato及其同事报道了使用乙酰胆碱直接输注在消退的冠状动脉瘤部位存在内皮功能障碍。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fukuda T, Akagi T, Ishibashi M, kato H, et al.: "Noninvasive evaluation of myocardial ischemia in Kawasaki disease : Comparson between dipyridamole stress thallium imaging and exercise stress test." Am Heart J. 135:. 482-487 (1998)
Fukuda T、Akagi T、Ishibashi M、kato H 等人:“川崎病心肌缺血的无创评估:双嘧达莫应激铊成像与运动应激测试之间的比较。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Higuchi T,Seki N,Kato H,Itoh K,et al: "Polymorphism of the 5'flanking region of the human tumor necrosis factor-alphgene in Japanese" Tissue Antigen. 51. 605-61 (1998)
Higuchi T,Seki N,Kato H,Itoh K,et al:“日本人肿瘤坏死因子-α基因 5 侧翼区域的多态性”组织抗原。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Wright DA: "Treatment of immune globulin resistant Kawasaki disease" J Pediatr. 129. 483-484 (1996)
Wright DA:“免疫球蛋白抵抗性川崎病的治疗”J Pediatr。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fukuda T, Akagi T, Ishibashi M, kato H, et al.: "Noninvasive evaluation of myocardial ischemia in Kawasaki disease : Comparison between dipyridamole stress thallium imaging and exercise stress test." Am Heart J. 135. 482-487 (1998)
Fukuda T、Akagi T、Ishibashi M、kato H 等人:“川崎病心肌缺血的无创评估:双嘧达莫应激铊成像与运动应激测试之间的比较。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yanagawa H: "Use of gammaglobulin for Kawasaki disease" Pediatr Cardiol. 18. 9-23 (1997)
Yanakawa H:“使用丙种球蛋白治疗川崎病”Pediatr Cardiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATO Hirohisa其他文献
KATO Hirohisa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATO Hirohisa', 18)}}的其他基金
Identification and characterization of biofilm regulatory autolysins
生物膜调节自溶素的鉴定和表征
- 批准号:
23592746 - 财政年份:2011
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel drugs to control oral biofilms towards clinical application
开发控制口腔生物膜的新药并走向临床应用
- 批准号:
20592181 - 财政年份:2008
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene therapy for induction of immunological tolerance in organ allografts
诱导同种异体器官移植免疫耐受的基因治疗
- 批准号:
13671253 - 财政年份:2001
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vasculitis in Kawasaki disease : the molecular and vascular biological studies
川崎病的血管炎:分子和血管生物学研究
- 批准号:
10470183 - 财政年份:1998
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Development of the new transctaneous occlusion system for patent ductus arteriosus
新型经皮动脉导管未闭封堵系统的开发
- 批准号:
08557053 - 财政年份:1996
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on Etiology and Pathogenesis of Kawasaki Disease
川崎病病因及发病机制研究
- 批准号:
07307011 - 财政年份:1995
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of cause of Kawasaki disease, molecular infecto-immunolgical analysis
川崎病病因调查、分子感染免疫学分析
- 批准号:
06454310 - 财政年份:1994
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
cDNA cloning of the recepters for the members of TGFbeta superfamily
TGFbeta超家族成员受体的cDNA克隆
- 批准号:
05671566 - 财政年份:1993
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Morphological and hemodynamic changes of the fetal heart : chronological evaluation from fetus to newborn
胎儿心脏的形态和血流动力学变化:从胎儿到新生儿的时间顺序评估
- 批准号:
04670627 - 财政年份:1992
- 资助金额:
$ 6.14万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
小胶质细胞的IL-6/JAK/STAT3/MCP-1信号途径在MS/EAE发病过程中的作用
- 批准号:81070958
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
- 批准号:
10722515 - 财政年份:2023
- 资助金额:
$ 6.14万 - 项目类别:
Using genomic modifiers to mechanistically link clonal hematopoiesis of indeterminate potential penetrance to coronary artery disease
使用基因组修饰剂将不确定潜在外显率的克隆造血与冠状动脉疾病机械联系起来
- 批准号:
10664184 - 财政年份:2023
- 资助金额:
$ 6.14万 - 项目类别:
Examining Susceptibility and Resistance Phenotypes to Enhance Understanding of the Genetic Basis of Major Coronary Artery Disease in Type 1 Diabetes
检查易感性和耐药表型以增强对 1 型糖尿病主要冠状动脉疾病遗传基础的了解
- 批准号:
10506443 - 财政年份:2022
- 资助金额:
$ 6.14万 - 项目类别:
Examining Susceptibility and Resistance Phenotypes to Enhance Understanding of the Genetic Basis of Major Coronary Artery Disease in Type 1 Diabetes
检查易感性和耐药表型以增强对 1 型糖尿病主要冠状动脉疾病遗传基础的了解
- 批准号:
10672463 - 财政年份:2022
- 资助金额:
$ 6.14万 - 项目类别:
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study
冠状动脉钙对老年人降脂事件和益处的实用评估:CAC 可预防的辅助研究
- 批准号:
10674482 - 财政年份:2021
- 资助金额:
$ 6.14万 - 项目类别:
Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults
美国不同西班牙裔/拉丁裔成年人的冠状动脉钙及其与保护/危险因素和表观遗传模式的关系
- 批准号:
10654571 - 财政年份:2021
- 资助金额:
$ 6.14万 - 项目类别:
Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults
美国不同西班牙裔/拉丁裔成年人的冠状动脉钙及其与保护/危险因素和表观遗传模式的关系
- 批准号:
10404926 - 财政年份:2021
- 资助金额:
$ 6.14万 - 项目类别:
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study
冠状动脉钙对老年人降脂事件和益处的实用评估:CAC 可预防的辅助研究
- 批准号:
10296788 - 财政年份:2021
- 资助金额:
$ 6.14万 - 项目类别:
Genome-wide association study of coronary artery disease in individuals of African ancestry
非洲血统个体冠状动脉疾病的全基因组关联研究
- 批准号:
10278230 - 财政年份:2021
- 资助金额:
$ 6.14万 - 项目类别:
Genome-wide association study of coronary artery disease in individuals of African ancestry
非洲血统个体冠状动脉疾病的全基因组关联研究
- 批准号:
10685985 - 财政年份:2021
- 资助金额:
$ 6.14万 - 项目类别: